Welcome to LookChem.com Sign In|Join Free
  • or
1H-Imidazole, 1-[(phenylmethoxy)methyl]- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

49822-58-4

Post Buying Request

49822-58-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

49822-58-4 Usage

Explanation

The compound is composed of 11 carbon atoms, 12 hydrogen atoms, 2 nitrogen atoms, and 1 oxygen atom.

Explanation

It is a derivative of the imidazole ring, which is a five-membered heterocyclic ring containing three carbon atoms, two nitrogen atoms, and one oxygen atom.

Explanation

The compound has a phenyl ring attached to the imidazole ring through a methoxy-methyl group, which is a CH2-O-CH3 unit.

Explanation

It is used in pharmaceutical and research applications due to its ability to interact with biological receptors and enzymes.

Explanation

The compound has shown potential as an antifungal and anti-inflammatory agent, making it a candidate for further research and development in these areas.

Explanation

It may have potential applications in the development of new drugs and medicinal compounds, particularly those targeting biological receptors and enzymes.

Explanation

As a derivative of imidazole, the compound may exhibit reactivity with various chemical groups, which can be exploited in the synthesis of new compounds and drug candidates.

Explanation

The compound's solubility profile may vary depending on the solvent used, which can be important for its formulation and administration in pharmaceutical applications.

Explanation

The stability of the compound under different conditions (e.g., temperature, pH, light exposure) can impact its suitability for various applications, including drug development and storage.

Explanation

The compound's toxicity and safety profile should be evaluated to determine its potential for use in pharmaceutical applications and to ensure the safety of patients and researchers.

Structure

1H-Imidazole derivative

Phenyl Ring Attachment

Via a methoxy-methyl group

Check Digit Verification of cas no

The CAS Registry Mumber 49822-58-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,9,8,2 and 2 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 49822-58:
(7*4)+(6*9)+(5*8)+(4*2)+(3*2)+(2*5)+(1*8)=154
154 % 10 = 4
So 49822-58-4 is a valid CAS Registry Number.

49822-58-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-[(phenylmethoxy)methyl]-1H-imidazole

1.2 Other means of identification

Product number -
Other names 1-[(benzyloxy)methyl]-1H-imidazole

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:49822-58-4 SDS

49822-58-4Relevant academic research and scientific papers

Extending pummerer reaction chemistry: Application to the assembly of the pentacyclic core of dibromopalau'amine

Feldman, Ken S.,Nuriye, Ahmed Yimam

scheme or table, p. 4532 - 4535 (2010/12/25)

A pentacyclic model system featuring the trans azabicyclo[3.3.0]octane unit of dibromopalau'amine was prepared with complete diastereoselectivity in the polycyclic core from a tricyclic precursor. The key transformations of this sequence include (a) a Pum

Further Studies on the Protection of Histidine Side Chains in Peptide Synthesis: The Use of the ?-Benzyloxymethyl Group

Brown, Tom,Jones, John H.,Richards, John D.

, p. 1553 - 1562 (2007/10/02)

Further studies on the use in peptide synthesis of N(?)-phenacyl protection for histidine side chains have shown that whilst this prevents the side chain-induced racemization which can occur if there is a lone pair of electrons available at the ?-nitrogen, there are concomitant drawbacks.As an alternative approach to the racemisation problem, the effect of halogenation of the heterocyclic ring carbons (to diminish the availability of the ?-nitrogen lone pair) has been investigated.This gives derivatives which are convenient in both classical and solid-phase applications, the halogen modifying groups being removed at the last stage by catalytic hydrogenolysis over a rhodium catalyst.Racemization is suppressed as expected, but it is not eleminated completely: direct blockade of the ?-nitrogen appears to be indispensable for its complete prohibition.Protection of the ?-nitrogen with a benzyloxymethyl group has now been found to be much more satisfactory than the use of the phenacyl group for this purpose.A ?-benzyloxymethyl substituent not only prohibits side chain-induced racemisation but also gives derivatives with convenient physical properties which can be incorporated into well estblished classical and solid-phase strategies without the need for any novel or additional operations or changes in protocol.The protecting group is stable to basic conditions, to trifluoroacetic acid, and to aqueous solutions of carboxylic acids, but is cleaved cleanly and rapidly by hydrogen bromide in trifluoroacetic acid or by catalytic hydrogenolysis.N(α)-t-Butoxycarbonyl-N(?)-benzyloxymethyl-L-histidine has been prepared in good yield by a simple procedure from an easily accessible intermediate and isolated as a crystalline solid; its use has been demonstrated by a number of exercises including a solid-phase synthesis of 5-isoleucine-angiotensin II and a classical synthesis of trihistidine.

Analgesic imidazolemethanols

-

, (2008/06/13)

α,α-Diarylimidazole-2-methanols of the general formula STR1 wherein R1 -R10 are the same or different and each represents a hydrogen or halogen atom or a trifluoromethyl or tertiary butyl group, with at least one of said R1 -R10 being halogen, trifluoromethyl or tertiary butyl; R11 and R12 are the same or different and each represents a hydrogen atom, an alkyl group, a phenyl group or a halogen-or trifluoromethyl-substituted phenyl group; and R13 represents a hydrogen atom or a lower alkyl group, a lower alkoxymethyl group, a phenylalkyl group (optionally substituted in the phenyl moiety by one or more halogen atoms or alkyl or trifluoromethyl groups), an alkenyl group, a phenyl(lower)alkoxymethyl group (optionally substituted in the phenyl moiety by one or more halogen atoms or alkyl or trifluoromethyl groups) or a benzenesulfonyl group (in which the phenyl moiety is optionally substituted by one or more alkyl groups) are described. These compounds and their non-toxic acid addition salts have anorexient activity. Certain of these compounds have analgesic activity comparable to morphine but without its serious side effects. Processes for their manufacture and compositions for their use are described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 49822-58-4